BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14605983)

  • 21. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
    Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
    Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis.
    Björnsson E; Angulo P
    Am J Gastroenterol; 2007 Aug; 102(8):1677-82. PubMed ID: 17433022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
    Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
    Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary sclerosing cholangitis.
    Rodriguez HJ; Bass NM
    Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence of primary sclerosing cholangitis in patients after liver transplantation.
    Ołdakowska-Jedynak U; Nowak M; Mucha K; Foroncewicz B; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Patkowski W; Górnicka B; Paczkowska A; Michałowicz B; Pilecki T; Pawlak J; Krawczyk M; Paczek L
    Transplant Proc; 2006; 38(1):240-3. PubMed ID: 16504713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute cholangitis secondary to a common bile duct adenoma.
    Lou HY; Chang CC; Chen SH; Fang CL; Shih YH; Liu JD; Pan S
    Hepatogastroenterology; 2003; 50(52):949-51. PubMed ID: 12845956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience.
    Kaya M; de Groen PC; Angulo P; Nagorney DM; Gunderson LL; Gores GJ; Haddock MG; Lindor KD
    Am J Gastroenterol; 2001 Apr; 96(4):1164-9. PubMed ID: 11316165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholangiocarcinoma complicating primary sclerosing cholangitis.
    Rosen CB; Nagorney DM
    Semin Liver Dis; 1991 Feb; 11(1):26-30. PubMed ID: 1646485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curative resection of a huge bile duct cancer without pancreatoduodenectomy.
    Tanaka S; Hirohashi K; Kubo S; Yamamoto T; Uenishi T; Tanaka H; Shuto T; Takemura S; Ogawa M; Yamasaki K; Kinoshita H
    Hepatogastroenterology; 2004; 51(59):1292-4. PubMed ID: 15362736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of bile duct cancer in a 26-year-old man after resection of infantile choledochal cyst.
    Ono S; Sakai K; Kimura O; Iwai N
    J Pediatr Surg; 2008 Jun; 43(6):E17-9. PubMed ID: 18558159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined total hepatectomy, orthotopic liver transplantation and pancreatoduodenectomy for unresectable hilar bile duct carcinoma].
    He XS; Zhang S; Zhu XF; Ji Y; Zeng JX; Ma Y; Wang DP; Ju WQ; Wu LW; Li Z; Huang JF
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):302-5. PubMed ID: 16635386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholangiocarcinoma coincident with schistosomiasis japonica.
    Andoh H; Yasui O; Kurokawa T; Sato T
    J Gastroenterol; 2004 Jan; 39(1):64-8. PubMed ID: 14767737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholangiocarcinoma complicating recurrent primary sclerosing cholangitis after liver transplantation.
    Khorsandi SE; Salvans S; Zen Y; Agarwal K; Jassem W; Heaton N
    Transpl Int; 2011 Oct; 24(10):e93-6. PubMed ID: 21884553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
    Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
    World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cholangiocarcinoma of the distal bile duct--case presentation].
    Constantinoiu S; Bîrlă R; Iosif C; Cociu L; Gîndea C; Hoară P; Achim F
    Chirurgia (Bucur); 2010; 105(2):279-85. PubMed ID: 20540247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of primary sclerosing cholangitis.
    Björnsson E
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.
    Layfield LJ; Cramer H
    Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
    Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
    Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.